FDA urges maker to recall Limbrel after liver and lung injury reports
The FDA asked Primus Pharmaceuticals to recall a product touted as easing osteoarthritis but linked to liver injury and a lung condition.
The Food and Drug Administration has asked Primus Pharmaceuticals to recall a product touted to address “the metabolic processes associated with osteoarthritis” but that the agency says comes
